Pulished Date October, 2018
ID: 7604
Share on
Share on

Asia Pacific Biopharmaceutical Contract Manufacturing Market By Product Type (Insulin, Monoclonal Antibodies, Growth Factors, Interferons, Recombinant Proteins, Vaccines, Others), By Therapeutic Area (Infectious Disease, Cardiovascular Disease, Oncology, Metabolic Disease, Respiratory Disorder, Autoimmune Disease, Neurology, Ophthalmology, Others), By Application (Commercial And Clinical), By Region - Industry Analysis, Share, Size, Trends, Growth, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 7604
Pages: 145

Asia Pacific Biopharmaceutical Contract Manufacturing market size was about USD 1.26 billion in 2018. It is expected to raise at a CAGR of 9.38% and expand to USD 1.97 billion by 2023.

Biopharmaceuticals is a biological product manufactured and developed to address the prevention and treatment of various diseases. Recent advancements in biomanufacturing and biotechnology have triggered the growth of innovative technologies that are capable of addressing the difficulties related to the manufacture of Biopharmaceuticals. Consequently, there is a rise in Biopharmaceutical contract manufacturing market growth. Previously, the Biopharmaceutical market was aimed towards preventive Biopharmaceuticals and mass production against infectious diseases. The commencement of therapeutic Biopharmaceuticals has altered interest in the field by creating a method for Biopharmaceuticals to be industrialized for a variety of chronic and progressive ailments, which has endorsed the entry of a number of manufacturers and budding investors who are contending for a market investment in this potential market segment.

Global Biopharmaceutical Contract Market segmentation is done by Product Type (Insulin, Monoclonal Antibodies, Growth Factors, Interferons, Recombinant Proteins, Vaccines, Others), by Therapeutic Area (Infectious Disease, Cardiovascular Disease, Oncology, Metabolic Disease, Respiratory Disorder, Autoimmune Disease, Neurology, Ophthalmology, Others), and by Application (Commercial and Clinical).

Geographically, the Asia Pacific Biopharmaceutical contract manufacturing market is spread over major countries like India, China, Japan, Australia and others. Asia Biopharmaceutical spending forecasts show that, over-all, developing countries will see a higher rate of Biopharmaceutical sales growth, while the growth for developed countries is lower. In this region, majorly the infectious diseases and cancer treatment products have high growth due to pollution and other environmental factors.

The report features some of the leading companies operating in the Asia Pacific biopharmaceutical contract manufacturing market. Companies profiled include Lonza Group AG, Baxter Biopharma Solutions, Samsung Biologics Co., Ltd., Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim GmbH, Patheon N.V., Rentschler Biotechnologie GmbH, Biomeva GmbH, Probiogen AG, Cytovance Biologics, Inc., KBI Biopharma, Inc., WuXi Biologics, Abzena Plc, Vetter Pharma International GmbH, Sandoz International GmbH, Catalent, Inc., AbbVie Contract Manufacturing (An AbbVie Company), Ajinomoto Althea Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Introduction           

                                5.1.2 Insulin       

                                5.1.3 Monoclonal Antibodies     

                                5.1.4 Growth Factors     

                                5.1.5 Interferons             

                                5.1.6 Recombinant Protiens       

                                5.1.7 Vaccines   

                                5.1.8 Others      

                                5.1.9  Y-o-Y Growth Analysis, By Product Type   

                                5.1.10  Market Attractiveness Analysis, By Product Type               

                                5.1.11  Market Share Analysis, By Product Type

                5.2 Therapeutic Area                     

                                5.2.1 Introduction           

                                5.2.2 Infectious Disease               

                                5.2.3Cardiovascular Disease       

                                5.2.4 Oncology 

                                5.2.5 Metabolic Disease               

                                5.2.6 Respiratory Disorder           

                                5.2.7 Autoimmune Disease         

                                5.2.8 Neurology               

                                5.2.9 Ophthalmology     

                                5.2.10 Others    

                                5.2.11 Y-o-Y Growth Analysis, By Therapeutic Area          

                                5.2.12 Market Attractiveness Analysis, By Therapeutic Area        

                                5.2.13 Market Share Analysis, By Therapeutic Area          

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Clinical       

                                5.3.3 Commercial            

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5 Market Attractiveness Analysis, By Application       

                                5.3.6 Market Share Analysis, By Application        

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product Type

                                                6.1.3.3 By Therapeutic Area

                                                6.1.3.4 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product Type

                                                6.1.4.3 By Therapeutic Area

                                                6.1.4.4 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product Type

                                                6.1.5.3 By Therapeutic Area

                                                6.1.5.4 By Application

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Patheon N.V.                             

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2Rentschler Biotechnologie GmbH                      

                 8.3 AbbVie Contract Manufacturing (An AbbVie Company)                        

                8.4 Biomeva GmbH                        

                8.5 Boehringer Ingelheim GmbH                              

                8.6 WuXi Biologics                           

                 8.7 Abzena Plc                 

                8.8 Lonza Group AG                       

                8.9 Samsung Biologics Co.                            

                8.10 Ajinomoto Althea, Inc.                        

                8.11 Fujifilm Diosynth Biotechnologies                  

                8.12 Probiogen AG                         

                8.13 Sandoz International GmbH                              

                8.14 KBI Biopharma, Inc.                              

                8.15 Baxter Biopharma Solutions                              

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product Type, by  Therapeutic Area along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market                                                                                                                           
  1. Asia Pacific Bio Pharmaceutical Contract Manufacturing Market By Product Type , From 2018-2023 ( USD Billion )
  2. Asia Pacific Insulin Market By Region, From 2018-2023 ( USD Billion )
  3. Asia Pacific  Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Billion )
  4. Asia Pacific  Growth Factors, Market By Region, From 2018-2023 ( USD Billion )
  5. Asia Pacific  Interferons Market By Region, From 2018-2023 ( USD Billion )
  6. Asia Pacific  Recombinant Proteins Market By Region, From 2018-2023 ( USD Billion )
  7. Asia Pacific Vaccines Market By Region, From 2018-2023 ( USD Billion )
  8. Asia Pacific  Others Market By Region, From 2018-2023 ( USD Billion )
  9. Asia Pacific Bio Pharmaceutical Contract Manufacturing Market By Therapeutic Area, From 2018-2023 ( USD Billion )
  10. Asia Pacific Infectious Disease Market By Region, From 2018-2023 ( USD Billion )
  11. Asia Pacific  Cardiovascular Disease Market By Region, From 2018-2023 ( USD Billion )
  12. Asia Pacific Oncology Market By Region, From 2018-2023 ( USD Billion )
  13. Asia Pacific  Metabolic Disease Market By Region, From 2018-2023 ( USD Billion )
  14. Asia Pacific  Respiratory Disorder Market By Region, From 2018-2023 ( USD Billion )
  15. Asia Pacific  Autoimmune Disease Market By Region, From 2018-2023 ( USD Billion )
  16. Asia Pacific  Neurology Market By Region, From 2018-2023 ( USD Billion )
  17. Asia Pacific  Ophthalmology Market By Region, From 2018-2023 ( USD Billion )
  18. Asia Pacific  Others Market By Region, From 2018-2023 ( USD Billion )
  19. Asia Pacific Bio Pharmaceutical Contract Manufacturing Market By Application, From 2018-2023 ( USD Billion )
  20. Asia Pacific Commercial  Market By Region, From 2018-2023 ( USD Billion )
  21. Asia Pacific  Clinical Market By Region, From 2018-2023 ( USD Billion )
  22. Japan Bio Pharmaceutical Contract Manufacturing Market By Product Type , From 2018-2023 ( USD Billion )
  23. Japan Bio Pharmaceutical Contract Manufacturing Market By Therapeutic Area, From 2018-2023 ( USD Billion )
  24. Japan Bio Pharmaceutical Contract Manufacturing Market By Application, From 2018-2023 ( USD Billion )
  25. China Bio Pharmaceutical Contract Manufacturing Market By Product Type , From 2018-2023 ( USD Billion )
  26. China Bio Pharmaceutical Contract Manufacturing Market By Therapeutic Area, From 2018-2023 ( USD Billion )
  27. China Bio Pharmaceutical Contract Manufacturing Market By Application, From 2018-2023 ( USD Billion )
  28. India Bio Pharmaceutical Contract Manufacturing Market By Product Type , From 2018-2023 ( USD Billion )
  29. India Bio Pharmaceutical Contract Manufacturing Market By Therapeutic Area, From 2018-2023 ( USD Billion )
  30. India Bio Pharmaceutical Contract Manufacturing Market By Application, From 2018-2023 ( USD Billion )
  31. Australia Bio Pharmaceutical Contract Manufacturing Market By Product Type , From 2018-2023 ( USD Billion )
  32. Australia Bio Pharmaceutical Contract Manufacturing Market By Therapeutic Area, From 2018-2023 ( USD Billion )
  33. Australia Bio Pharmaceutical Contract Manufacturing Market By Application, From 2018-2023 ( USD Billion )
  34. South Korea Bio Pharmaceutical Contract Manufacturing Market By Product Type , From 2018-2023 ( USD Billion )
  35. South Korea Bio Pharmaceutical Contract Manufacturing Market By Therapeutic Area, From 2018-2023 ( USD Billion )
  36. South Korea Bio Pharmaceutical Contract Manufacturing Market By Application, From 2018-2023 ( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Request Sample